gain weight back after semaglutide Patients regain rapidly stopping weight loss drugs – but still keep off a quarter of weight lost Stopping Semaglutide: How to Keep

FDA has stated that the shortage of semaglutide injection products is resolved (FDA update dated February 21, 2025)

GLP-1 medications work differently because they alter the biological reward system directly

While Medicare does not cover medications when prescribed solely for weight loss, the Wegovy pill may be covered if prescribed for cardiovascular risk reduction

Patients typically experience decreased hunger, faster satiety, reduced cravings, and increased energy, alongside improved cardiovascular and metabolic health markers

Fact: Many GLP-1 medications are specifically indicated for people with heart disease to help reduce the risk of future cardiac events

This article describes the published research literature on these two peptides for orientation purposes within the UK research community